The Bacteriology and Its Virulence Factors in Neonatal Infections: Threats to Child Survival Strategies

Table 3

The multidrugs resistance pattern of the isolates.

Organisms	Resistance of the isolates to antibiotics																				ANOVA
	TIC (100)		KF (100)		CAZ (100)		C/S (60.95)		MEM (87.91)		LVD (11.15)		CXM (100)		PRL (100)		HFX (87.91)		HVX (73.54)
	B	UC	B	UC	B	UC	B	UC	B	UC	B	UC	B	UC	B	UC	B	UC	B	UC
S. aureus	100	100	100	100	100	100	41.7	75	100	100	0	25	100	100	100	100	100	100	100	37.5
E. coli	100	100	100	100	100	100	33.4	12.5	83.3	87.5	16.7	12.5	100	100	100	100	33.3	100	33.3	75
Pseudomonas	100	100	100	100	100	100	100	75	80	87.5	0	25	100	100	100	100	80	100	80	62.5
Salmonella	100	100	100	100	100	100	50	100	75	90	0	10	100	100	100	100	100	90	100	100
ANOVA

KEY:
UC: umbilical cord swab samples and B: peripheral blood samples. Figures in brackets represent mean resistance of the isolates to the drugs tested. TIC: ticarcillin 75μg, KF: cephalothin 30μg, CAZ: ceftazidime 30 μg, C/S: ceftriaxone/sulbactam 30 μg, MEM: meropenem 10μg, LVD: levofloxacin 5 μg, CXM: cefuroxime 30 μg, PRL: piperacillin 110 μg, HVX: azithromycin 15 μg, and HFX: ceftriaxone 30 μg.